HEC116094 / HEC Pharm - LARVOL DELTA

Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects (clinicaltrials.gov) - P1 | N=118 | Completed | Sponsor: Sunshine Lake Pharma Co., Ltd. | Not yet recruiting ➔ Completed | Trial completion date: Jan 2022 ➔ Oct 2022 | Trial primary completion date: Jan 2022 ➔ Oct 2022

Trial completion • Trial completion date • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases

Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects (clinicaltrials.gov) - P1; N=130; Not yet recruiting; Sponsor: Sunshine Lake Pharma Co., Ltd.

New P1 trial • Infectious Disease • Respiratory Diseases